Tazarotene 1 mg/ML [Avage]
RxNorm 575697
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 575697 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: tazarotene 1 mg/ML [Avage].
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SBDC
Semantic Branded Drug Component (SBDC):
Tazarotene 1 mg/ML [Avage]
(Atom ID: 2291745)
Patient Education
Tazarotene Topical
Tazarotene (Tazorac, Fabior) is used to treat acne. Tazarotene (Tazorac) is also used to treat psoriasis (a skin disease in which red, scaly patches form on some areas of the body). Tazarotene (Avage) is used to reduce facial wrinkling and discoloration in patients who are also using other skin care and sunlight avoidance programs. Tazarotene is in a class of medications called retinoids. It works to treat acne and psoriasis by slowing skin cell overgrowth and decreasing skin cell inflammation, which can lead to acne or psoriasis. It works to reduce facial wrinkles and discoloration by causing an increase in the thickness of the outer skin layers.
[Learn More]
* Please review the disclaimer below.